Skip to main content

Advertisement

Table 2 Response rates to chronic hepatitis B treatments [1720]

From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

24th week TDF ETV 3TC LAM LdT TDF ETV 3TC LAM LdT
<300 84.8 84.8 73.0 71.0 80.0 48.9 37.0 34.0 32.0 45.0
300–104 9.7 9.7 15.0 20.0 15.0 32.5 40.0 26.0 31.0 31.0
104–105 2.7 2.7 3.6 2.7 1.5 8.9 11.0 12.0 11.1 7.2
105–106 0.2 0.2 1.5 1.1 0.6 0.8 1.0 5.0 4.6 3.0
>106 2.7 2.7 6.9 5.2 2.9 8.9 11.0 23.0 21.3 13.8
48th week           
<300 93.2 93.3 75.6 71.4 88.3 76.1 69.1 39.8 40.4 60.0
300–104 4.2 4.1 12.5 18.4 8.0 19.1 24.7 18.2 28.1 21.5
104–105 1.6 1.6 5.1 7.5 3.3 3.4 4.4 11.7 18.1 13.8
105–106 0.3 0.3 2.0 0.8 0.1 0.5 0.6 9.3 4.1 1.4
>106 0.6 0.6 4.8 1.9 0.3 0.9 1.2 21.0 9.3 3.3
  1. Values are expressed as %